表紙
市場調查報告書
商品編碼
795304

美國的消化管內視鏡設備市場 (2019-2025年):13報告套組

Gastrointestinal Endoscopic Device Market Report Suite | United States | 2019-2025 | MedSuite (Includes 13 reports)

出版日期: | 出版商: iData Research Inc. | 英文 676 Pages | 商品交期: 最快1-2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

本報告套組,提供美國的消化管內視鏡設備的市場調查,對象疾病概要,患者人口及治療數量,產品系列,臨床試驗及回收目標產品,各產品種類的主要趨勢,市場成長的各種影響因素分析,市場規模的變化與預測,競爭環境與市場佔有率等彙整資料。

疾病概要

  • 解剖學的結構
  • 診斷、治療
  • 患者人口統計

產品評估

  • 產品系列
    • GI內視鏡
    • 膠囊內視鏡
    • 虛擬大腸內視鏡
    • 支架置入、擴張用設備
    • ERCP (經內視鏡逆行性膽胰管攝影術) 用設備
    • 切片鉗、息肉切除用圈套、抽吸生檢用細針
    • 異物回收、試驗片消除用設備
    • 止血用設備
    • 經腸營養設備
    • 逆流防止用設備
    • 巴瑞特氏食道症切除用設備
  • FDA回收產品
  • 臨床試驗中的產品

美國的消化管內視鏡設備市場:概要

  • 市場概要
  • 趨勢分析:各種類
  • 成長推動因素、抑制因素
  • 市場佔有率分析
  • M&A
  • 企業簡介
  • SWOT分析

治療數量

  • 治療數量
    • 概要
    • 消化管內視鏡治療
    • 膠囊內視鏡治療
    • 虛擬內視鏡治療
    • 支架置入
    • 擴張治療
    • 組織切片檢查
    • 息肉切除
    • 檢體回收
    • 去除異物
    • 止血
    • 經腸營養置管
    • 逆流防止設備拘留
    • 巴瑞特氏食道症切除

消化管內視鏡市場

  • 市場概要
  • 市場分析、預測
    • 整體市場
    • 大腸內視鏡
    • S狀結腸鏡
    • 十二指腸鏡
    • 小腸內視鏡
    • 超音波內視鏡
    • 雙球囊內視鏡
    • 胃內視鏡
    • 第三方整備內視鏡
  • 成長推動因素、抑制因素
  • 市場佔有率分析

膠囊內視鏡市場

  • 市場概要
  • 市場分析、預測
    • 相機膠囊
    • 工作站
    • 資料記錄器
  • 成長推動因素、抑制因素
  • 市場佔有率分析

大腸內視鏡檢驗軟體市場

  • 市場分析、預測
  • 成長推動因素、抑制因素
  • 市場佔有率分析

支架置入、擴張用設備市場

  • 市場概要
  • 市場分析、預測
    • 整體市場
    • 十二指腸支架
    • 結腸支架
    • 食道擴張球囊
    • 十二指腸擴張球囊
    • 結腸擴張球囊
  • 成長推動因素、抑制因素
  • 市場佔有率分析

ERCP (經內視鏡逆行性膽胰管攝影術) 用設備市場

  • 市場概要
  • 市場分析、預測
    • 括約肌解剖
    • 膽囊結石消除用球囊
    • 膽囊結石消除用籃
    • 膽管擴張用球囊
    • 胰臟、肝膽管支架全體
    • 膽道結石碾碎器
    • ERCP導管導引線
    • ERCP導管
  • 成長推動因素、抑制因素
  • 市場佔有率分析

切片鉗、息肉切除用圈套、抽吸生檢用細針市場

  • 市場概要
  • 市場分析、預測
  • 成長推動因素、抑制因素
  • 市場佔有率分析

檢體回收、去除異物用設備市場

  • 市場概要
  • 市場分析、預測
  • 成長推動因素、抑制因素
  • 市場佔有率分析

止血用設備市場

  • 市場概要
  • 市場分析、預測
    • 高頻手術刀
    • 止血探針
    • 結紮裝置
    • 硬化療法用針頭
  • 成長推動因素、抑制因素
  • 市場佔有率分析

經腸營養用設備市場

  • 市場概要
  • 市場分析、預測
    • 腸道餵食幫浦
    • 經腸營養管
    • 經腸營養套組
  • 成長推動因素、抑制因素
  • 市場佔有率分析

逆流防止設備市場

  • 市場環境
  • 市場分析、預測
  • 成長推動因素、抑制因素
  • 市場佔有率分析

巴瑞特氏食道症切除用設備市場

  • 市場概要
  • 市場分析、預測
  • 成長推動因素、抑制因素
  • 市場佔有率分析
目錄
Product Code: iDATA_USGI19_MS

The GI endoscopic device market includes GI endoscopes, capsule endoscopy, virtual colonoscopy software, stenting and dilation devices, endoscopic retrograde cholangiopancreatography (ERCP) devices, biopsy forceps, polypectomy snares, endoscopic ultrasound (EUS) needles, foreign-body and specimen removal devices, hemostasis devices, enteral feeding devices, anti-reflux devices and Barrett's esophagus ablation devices.

In 2018, the largest segment in the GI endoscopic device market was the GI endoscope market. The majority of total GI endoscope unit sales consisted of colonoscopes used in the hospital setting, either at a designated endoscopy room or general surgery suite, with the balance being used in the outpatient centers. Although there is a general downward trend in prices across the GI endoscope segments, it will be moderated by an upward trend in segments such as colonoscopes, where users are converting towards new premium-priced products.

TABLE OF CONTENTS

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW

COMPETITIVE ANALYSIS

MARKET TRENDS

MARKET DEVELOPMENTS

PROCEDURE NUMBERS

PROCEDURE CODES INVESTIGATED

MARKETS INCLUDED

KEY REPORT UPDATES

VERSION HISTORY

RESEARCH METHODOLOGY

  • Step 1: Project Initiation & Team Selection
  • Step 2: Prepare Data Systems and Perform Secondary Research
  • Step 3: Preparation for Interviews & Questionnaire Design
  • Step 4: Performing Primary Research
  • Step 5: Research Analysis: Establishing Baseline Estimates
  • Step 6: Market Forecast and Analysis
  • Step 7: Identify Strategic Opportunities
  • Step 8: Final Review and Market Release
  • Step 9: Customer Feedback and Market Monitoring

DISEASE OVERVIEW

  • 2.1. BASIC ANATOMY
  • 2.2. DISEASE TREATMENT & DIAGNOSTICS
    • 2.2.1. Gastroesophageal Reflux Disease
    • 2.2.2. Barrett's Esophagus
    • 2.2.3. GI Cancer
    • 2.2.4. GI bleeding
    • 2.2.5. Bile Duct Diseases
    • 2.2.6. Crohn's Disease
    • 2.2.7. Peptic Ulcer Disease
    • 2.2.8. Intestinal Pseudo-Obstruction and Ogilvie Syndrome
  • 2.3. PATIENT DEMOGRAPHICS
    • 2.3.1. GI Disorders
      • 2.3.1.1. General Statistics of GI Disorders for Different Years for the United States
      • 2.3.1.2. Abdominal Wall Hernia
      • 2.3.1.3. Chronic Constipation
      • 2.3.1.4. Diverticular Disease
      • 2.3.1.5. Prescriptions
      • 2.3.1.6. Gastroesophageal Reflux Disease
      • 2.3.1.7. Gastrointestinal Infections
      • 2.3.1.8. Hemorrhoids
      • 2.3.1.9. Inflammatory Bowel Disease
      • 2.3.1.10. Liver Disease
      • 2.3.1.11. Pancreatitis
      • 2.3.1.12. Peptic Ulcer Diseases
    • 2.3.2. GI Cancers

PRODUCT ASSESSMENT

  • 3.1. INTRODUCTION
  • 3.2. PRODUCT PORTFOLIOS
    • 3.2.1. GI Endoscopy
    • 3.2.2. Capsule Endoscopy
    • 3.2.3. Virtual Colonoscopy
    • 3.2.4. Stenting and Dilation Devices
    • 3.2.5. Endoscopic Retrograde Cholangiopancreatography (ERCP) Devices
    • 3.2.6. Biopsy Forceps, Polypectomy Snares, Fine-Needle Aspiration
    • 3.2.7. Foreign Body Retrieval and Specimen Removal Devices
    • 3.2.8. Hemostasis Devices
    • 3.2.9. Enteral Feeding Devices
    • 3.2.10. Anti-Reflux Devices
    • 3.2.11. Barrett's Esophagus Ablation Devices
  • 3.3. FDA RECALLS
    • 3.3.1. Boston Scientific
      • 3.3.1.1. ERCP
    • 3.3.2. Cook Medical
      • 3.3.2.1. Stenting and Dilation Devices
      • 3.3.2.2. Biopsy Forceps, Polypectomy Snares and Fine-Needle Aspiration
      • 3.3.2.3. Hemostasis Devices
    • 3.3.3. Fujifilm
    • 3.3.4. Avanos Medical
      • 3.3.4.1. Enteral Feeding
    • 3.3.5. Olympus
      • 3.3.5.1. Gastrointestinal Endoscopy
    • 3.3.6. Pentax Medical
      • 3.3.6.1. Gastrointestinal Endoscopy
    • 3.3.7. US Endoscopy
      • 3.3.7.1. Foreign Body Retrieval and Specimen Removal
  • 3.4. CLINICAL TRIALS
    • 3.4.1. Boston Scientific
      • 3.4.1.1. Stenting & Dilation
      • 3.4.1.2. ERCP
      • 3.4.1.3. Biopsy Forceps, Polypectomy Snares, Fine-Needle Aspiration
      • 3.4.1.4. Hemostasis Devices
    • 3.4.2. Cook Medical
      • 3.4.2.1. Stenting and Dilation Devices
      • 3.4.2.2. ERCP
      • 3.4.2.3. Biopsy Forceps, Polypectomy Snares, Fine-Needle Aspiration
      • 3.4.2.4. Hemostasis Devices
    • 3.4.3. EndoGastric
      • 3.4.3.1. Anti-Reflux Devices for Treatment of GERD
    • 3.4.4. ERBE
      • 3.4.4.1. Hemostasis Devices
    • 3.4.5. Fujifilm
    • 3.4.6. Medtronic
      • 3.4.6.1. Capsule Endoscopy
      • 3.4.6.2. Barrett's Esophagus Ablation Devices
    • 3.4.7. Olympus
      • 3.4.7.1. Gastrointestinal Endoscopy
      • 3.4.7.2. Capsule Endoscopy
      • 3.4.7.3. Biopsy Forceps, Polypectomy Snares, Fine-Needle Aspiration
      • 3.4.7.4. Hemostasis Devices
    • 3.4.8. Pentax Medical
      • 3.4.8.1. Gastrointestinal Endoscopy

U.S. GASTROINTESTINAL ENDOSCOPIC DEVICE MARKET OVERVIEW

  • 4.1. INTRODUCTION
  • 4.2. MARKET OVERVIEW
  • 4.3. TREND ANALYSIS BY SEGMENT
  • 4.4. DRIVERS AND LIMITERS
    • 4.4.1. Market Drivers
    • 4.4.2. Market Limiters
  • 4.5. COMPETITIVE MARKET SHARE ANALYSIS
  • 4.6. MERGERS AND ACQUISITIONS
  • 4.7. COMPANY PROFILES
    • 4.7.1. Boston Scientific
    • 4.7.2. Cardinal Health
    • 4.7.3. CONMED
    • 4.7.4. Cook Medical
    • 4.7.5. EndoGastric Solutions
    • 4.7.6. ERBE
    • 4.7.7. Fujifilm
    • 4.7.8. GE Healthcare
    • 4.7.9. Avanos Medical
    • 4.7.10. Medline
    • 4.7.11. Medtronic
    • 4.7.12. Olympus
    • 4.7.13. Pentax Medical
    • 4.7.14. Siemens Healthineers
    • 4.7.15. STERIS
    • 4.7.16. US Endoscopy
    • 4.7.17. Vital Images, Inc.
  • 4.8. SWOT ANALYSIS
    • 4.8.1. Boston Scientific
    • 4.8.2. Cardinal Health
    • 4.8.3. CONMED
    • 4.8.4. Cook Medical
    • 4.8.5. EndoGastric Solutions
    • 4.8.6. ERBE
    • 4.8.7. Fujifilm
    • 4.8.8. GE Healthcare
    • 4.8.9. Avanos Medical
    • 4.8.10. Medline
    • 4.8.11. Medtronic
    • 4.8.12. Olympus
    • 4.8.13. Pentax Medical
    • 4.8.14. Siemens Healthineers
    • 4.8.15. STERIS
    • 4.8.16. US Endoscopy
    • 4.8.17. Vital Images, Inc.

PROCEDURE NUMBERS

  • 5.1. INTRODUCTION
  • 5.2. PROCEDURES
    • 5.2.1. Procedure Overview
    • 5.2.2. Gastrointestinal Endoscopy Procedures
      • 5.2.2.1. EGD Procedures
      • 5.2.2.2. Colonoscopy Procedures
      • 5.2.2.3. Sigmoidoscopy Procedures
      • 5.2.2.4. Enteroscopy Procedures
      • 5.2.2.5. Ultrasound Endoscopy Procedures
      • 5.2.2.6. ERCP Procedures
    • 5.2.3. Capsule Endoscopy Procedures
    • 5.2.4. Virtual Endoscopy Procedures
    • 5.2.5. Stenting Procedures
    • 5.2.6. Dilation Procedures
    • 5.2.7. Tissue Biopsy Procedures
    • 5.2.8. Polypectomy Snare Procedures
    • 5.2.9. Specimen Retrieval Procedures
    • 5.2.10. Foreign-Body Removal Procedures
    • 5.2.11. Hemostasis Procedures
    • 5.2.12. Enteral Feeding Tube Placement Procedures
    • 5.2.13. Anti-Reflux Device Implantation Procedures
    • 5.2.14. Barrett's Esophagus Ablation Procedures

GASTROINTESTINAL ENDOSCOPE MARKET

  • 6.1. INTRODUCTION
  • 6.2. MARKET OVERVIEW
  • 6.3. MARKET ANALYSIS AND FORECAST
    • 6.3.1. Total Gastrointestinal Endoscope Market
    • 6.3.2. Colonoscope Market
    • 6.3.3. Sigmoidoscope Market
    • 6.3.4. Duodenoscope Market
    • 6.3.5. Enteroscope Market
    • 6.3.6. Ultrasound Endoscope Market
    • 6.3.7. Double-Balloon Endoscope Market
    • 6.3.8. Gastroscope Market
    • 6.3.9. Third-Party Refurbished Endoscope Market
  • 6.4. DRIVERS AND LIMITERS
    • 6.4.1. Market Drivers
    • 6.4.2. Market Limiters
  • 6.5. COMPETITIVE MARKET SHARE ANALYSIS
    • 6.5.1. Gastrointestinal Endoscope
    • 6.5.2. Third-Party Endoscope Resale and Repair Market

CAPSULE ENDOSCOPY MARKET

  • 7.1. INTRODUCTION
  • 7.2. MARKET OVERVIEW
  • 7.3. MARKET ANALYSIS AND FORECAST
    • 7.3.1. Camera Capsule Market
    • 7.3.2. Workstation Market
    • 7.3.3. Data Recorder Market
  • 7.4. DRIVERS AND LIMITERS
    • 7.4.1. Market Drivers
    • 7.4.2. Market Limiters
  • 7.5. COMPETITIVE MARKET SHARE ANALYSIS

VIRTUAL COLONOSCOPY SOFTWARE MARKET

  • 8.1. INTRODUCTION
  • 8.2. MARKET ANALYSIS AND FORECAST
  • 8.3. DRIVERS AND LIMITERS
    • 8.3.1. Market Drivers
    • 8.3.2. Market Limiters
  • 8.4. COMPETITIVE MARKET SHARE ANALYSIS

STENTING AND DILATION DEVICE MARKET

  • 9.1. INTRODUCTION
  • 9.2. MARKET OVERVIEW
  • 9.3. MARKET ANALYSIS AND FORECAST
    • 9.3.1. Total Esophageal Stent Market
      • 9.3.1.1. Esophageal Covered-Metal Stent Market
      • 9.3.1.2. Esophageal Bare-Metal Stent Market
      • 9.3.1.3. Esophageal Plastic Stent Market
    • 9.3.2. Duodenal Stent Market
    • 9.3.3. Colonic Stent Market
    • 9.3.4. Total Esophageal Dilation Balloon Market
      • 9.3.4.1. Multi-Stage Esophageal Dilation Balloon Market
      • 9.3.4.2. Single-Stage Esophageal Dilation Balloon Market
    • 9.3.5. Duodenal Dilation Balloon Market
    • 9.3.6. Colonic Dilation Balloon Market
  • 9.4. DRIVERS AND LIMITERS
    • 9.4.1. Esophageal Stent Market
      • 9.4.1.1. Market Drivers
      • 9.4.1.2. Market Limiters
    • 9.4.2. Duodenal Stent Market
      • 9.4.2.1. Market Drivers
      • 9.4.2.2. Market Limiters
    • 9.4.3. Colonic Stent Market
      • 9.4.3.1. Market Drivers
      • 9.4.3.2. Market Limiters
    • 9.4.4. Esophageal Dilation Balloon Market
      • 9.4.4.1. Market Drivers
      • 9.4.4.2. Market Limiters
    • 9.4.5. Duodenal Dilation Balloon Market
      • 9.4.5.1. Market Drivers
      • 9.4.5.2. Market Limiters
    • 9.4.6. Colonic Dilation Balloon Market
      • 9.4.6.1. Market Drivers
  • 9.5. COMPETITIVE MARKET SHARE ANALYSIS
    • 9.5.1. Stenting and Dilation Device Market
    • 9.5.2. Esophageal Stent Market

ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY DEVICE MARKET

  • 10.1. INTRODUCTION
  • 10.2. MARKET OVERVIEW
  • 10.3. MARKET ANALYSIS AND FORECAST
    • 10.3.1. Sphincterotome Market
    • 10.3.2. Biliary Stone Removal Balloon Market
    • 10.3.3. Biliary Stone Removal Basket Market
    • 10.3.4. Biliary Dilation Balloon Market
    • 10.3.5. Total Biliary and Pancreatic Stent Market
      • 10.3.5.1. Total Biliary and Pancreatic Covered-Metal Stent Market
      • 10.3.5.1.1. Biliary and Pancreatic Standard Covered-Metal Stent Market
      • 10.3.5.1.2. Biliary and Pancreatic Lumen-Apposing Covered-Metal Stent Market
      • 10.3.5.2. Biliary and Pancreatic Bare-Metal Stent Market
      • 10.3.5.3. Biliary and Pancreatic Plastic Stent Market
    • 10.3.6. Biliary Lithotripter Market
    • 10.3.7. ERCP Guidewire Market
    • 10.3.8. ERCP Cannula Market
  • 10.4. DRIVERS AND LIMITERS
    • 10.4.1. Market Drivers
    • 10.4.2. Market Limiters
  • 10.5. COMPETITIVE MARKET SHARE ANALYSIS
    • 10.5.1. ERCP Device Market
    • 10.5.2. Biliary and Pancreatic Stent Market

BIOPSY FORCEPS, POLYPECTOMY SNARE AND EUS NEEDLE MARKET

  • 11.1. INTRODUCTION
  • 11.2. MARKET OVERVIEW
  • 11.3. MARKET ANALYSIS AND FORECAST
    • 11.3.1. Total Biopsy Forceps Market
      • 11.3.1.1. Cold Disposable Biopsy Forceps Market
      • 11.3.1.2. Hot Disposable Biopsy Forceps Market
      • 11.3.1.3. Cold Reusable Biopsy Forceps Market
      • 11.3.1.4. Hot Reusable Biopsy Forceps Market
    • 11.3.2. Polypectomy Snare Market
    • 11.3.3. Total EUS Needle Market
      • 11.3.3.1. Fine Needle Aspiration Market
      • 11.3.3.2. Fine Needle Biopsy Market
  • 11.4. DRIVERS AND LIMITERS
    • 11.4.1. Biopsy Forceps Market
      • 11.4.1.1. Market Drivers
      • 11.4.1.2. Market Limiters
    • 11.4.2. Polypectomy Snare Market
      • 11.4.2.1. Market Drivers
      • 11.4.2.2. Market Limiters
    • 11.4.3. EUS Needle Market
      • 11.4.3.1. Market Drivers
      • 11.4.3.2. Market Limiters
  • 11.5. COMPETITIVE MARKET SHARE ANALYSIS
    • 11.5.1. Biopsy Forceps Market
    • 11.5.2. EUS Needle Market

SPECIMEN RETRIEVAL AND FOREIGN-BODY REMOVAL DEVICE MARKET

  • 12.1. INTRODUCTION
  • 12.2. MARKET OVERVIEW
  • 12.3. MARKET ANALYSIS AND FORECAST
    • 12.3.1. Total Specimen Retrieval Device Market
      • 12.3.1.1. Polyp Retrieval Trap Market
      • 12.3.1.2. Specimen Retrieval Net Market
    • 12.3.2. Total Foreign-Body Removal Device Market
      • 12.3.2.1. Foreign-Body Removal Net Market
      • 12.3.2.2. Foreign-Body Removal Grasper Market
      • 12.3.2.3. Foreign-Body Removal Snare Market
  • 12.4. DRIVERS AND LIMITERS
    • 12.4.1. Market Drivers
    • 12.4.2. Market Limiters
  • 12.5. COMPETITIVE MARKET SHARE ANALYSIS
    • 12.5.1. Specimen Retrieval and Foreign-Body Removal Device Market
    • 12.5.2. Specimen Retrieval Device Market
    • 12.5.3. Foreign-Body Removal Device Market

HEMOSTASIS DEVICE MARKET

  • 13.1. INTRODUCTION
  • 13.2. MARKET OVERVIEW
  • 13.3. MARKET ANALYSIS AND FORECAST
    • 13.3.1. Total Electrosurgical Generator Market
      • 13.3.1.1. Electrosurgical Unit Market
      • 13.3.1.2. Argon Module Market
    • 13.3.2. Total Hemostasis Probe Market
      • 13.3.2.1. Total Electrosurgical Probe Market
      • 13.3.2.1.1. Conventional Electrosurgical Probe Market
      • 13.3.2.1.2. Injection-Needle Probe Market
      • 13.3.2.2. Heat Probe Market
      • 13.3.2.3. Argon Probe Market
    • 13.3.3. Total Ligation Device Market
      • 13.3.3.1. Ligation Band Market
      • 13.3.3.2. Ligation Clip Market
    • 13.3.4. Sclerotherapy Needle Market
  • 13.4. DRIVERS AND LIMITERS
    • 13.4.1. Market Drivers
    • 13.4.2. Market Limiters
  • 13.5. COMPETITIVE MARKET SHARE ANALYSIS
    • 13.5.1. Hemostasis Device Market
    • 13.5.2. Electrosurgical Generator Market
    • 13.5.3. Hemostasis Probe Market
    • 13.5.4. Electrosurgical Probe Market
    • 13.5.5. Ligation Device Market

ENTERAL FEEDING DEVICE MARKET

  • 14.1. INTRODUCTION
  • 14.2. MARKET OVERVIEW
  • 14.3. MARKET ANALYSIS AND FORECAST
    • 14.3.1. Enteral Feeding Pump Market
    • 14.3.2. Total Feeding Tube Market
      • 14.3.2.1. Total PEG Tube Market
      • 14.3.2.1.1. Initial Placement PEG Tube Market
      • 14.3.2.1.2. Total Replacement PEG Tube Market
      • 14.3.2.2. DPEJ Tube Market
      • 14.3.2.3. PEG-J Tube Market
      • 14.3.2.4. NG/NJ Tube Market
    • 14.3.3. Feeding Set Market
  • 14.4. DRIVERS AND LIMITERS
    • 14.4.1. Market Drivers
    • 14.4.2. Market Limiters
  • 14.5. COMPETITIVE MARKET SHARE ANALYSIS
    • 14.5.1. Enteral Feeding Device Market
    • 14.5.2. Feeding Tube Market
      • 14.5.2.1. PEG Tube Market

ANTI-REFLUX DEVICE MARKET

  • 15.1. INTRODUCTION
  • 15.2. MARKET LANDSCAPE
  • 15.3. MARKET ANALYSIS AND FORECAST
  • 15.4. DRIVERS AND LIMITERS
    • 15.4.1. Market Drivers
    • 15.4.2. Market Limiters
  • 15.5. COMPETITIVE MARKET SHARE ANALYSIS

BARRETT'S ESOPHAGUS ABLATION DEVICE MARKET

  • 16.1. INTRODUCTION
  • 16.2. MARKET OVERVIEW
  • 16.3. MARKET ANALYSIS AND FORECAST
    • 16.3.1. Ablation Device Market
    • 16.3.2. Ablation Catheter Market
  • 16.4. DRIVERS AND LIMITERS
    • 16.4.1. Market Drivers
    • 16.4.2. Market Limiters
  • 16.5. COMPETITIVE MARKET SHARE ANALYSIS

ABBREVIATIONS

LIST OF CHARTS

  • Chart 1-1: Endoscopic Gastrointestinal Device Market by Segment, U.S., 2015 - 2025
  • Chart 1-2: Endoscopic Gastrointestinal Device Market Overview, U.S., 2018 & 2025
  • Chart 4-1: Endoscopic Gastrointestinal Device Market by Segment, U.S., 2015 - 2025
  • Chart 4-2: Endoscopic Gastrointestinal Device Market Breakdown, U.S., 2018
  • Chart 4-3: Endoscopic Gastrointestinal Device Market Breakdown, U.S., 2025
  • Chart 4-4: Growth Rates by Segment, Endoscopic Gastrointestinal Device Market, U.S., 2015 - 2025
  • Chart 4-5: Leading Competitors, Gastrointestinal Endoscopic Device Market, U.S., 2018
  • Chart 5-1: Total Gastrointestinal Procedures by Type, U.S., 2015 - 2025
  • Chart 5-2: Gastrointestinal Endoscopy Procedures, U.S., 2015 - 2025
  • Chart 5-3: Capsule Endoscopy Procedures, U.S., 2015 - 2025
  • Chart 5-4: Virtual Endoscopy Procedures, U.S., 2015 - 2025
  • Chart 5-5: Stenting Procedures by Anatomy, U.S., 2015 - 2025
  • Chart 5-6: Dilation Procedures by Anatomy, U.S., 2015 - 2025
  • Chart 5-7: Tissue Biopsy Procedures by Modality, U.S., 2015 - 2025
  • Chart 5-8: Polypectomy Snare Procedures, U.S., 2015 - 2025
  • Chart 5-9: Specimen Retrieval Procedures, U.S., 2015 - 2025
  • Chart 5-10: Foreign-Body Removal Procedures, U.S., 2015 - 2025
  • Chart 5-11: Hemostasis Procedures, U.S., 2015 - 2025
  • Chart 5-12: Enteral Feeding Tube Placement Procedures, U.S., 2015 - 2025
  • Chart 5-13: Anti-Reflux Device Implantation Procedures, U.S., 2015 - 2025
  • Chart 5-14: Barrett's Esophagus Ablation Procedures, U.S., 2015 - 2025
  • Chart 6-1: Gastrointestinal Endoscope Market by Segment, U.S., 2015 - 2025
  • Chart 6-2: Gastrointestinal Endoscope Market Breakdown, U.S., 2018
  • Chart 6-3: Gastrointestinal Endoscope Market Breakdown, U.S., 2025
  • Chart 6-4: Total Gastrointestinal Endoscope Market, U.S., 2015 - 2025
  • Chart 6-5: Colonoscope Market, U.S., 2015 - 2025
  • Chart 6-6: Sigmoidoscope Market, U.S., 2015 - 2025
  • Chart 6-7: Duodenoscope Market, U.S., 2015 - 2025
  • Chart 6-8: Enteroscope Market, U.S., 2015 - 2025
  • Chart 6-9: Ultrasound Endoscope Market, U.S., 2015 - 2025
  • Chart 6-10: Double-Balloon Endoscope Market, U.S., 2015 - 2025
  • Chart 6-11: Gastroscope Market, U.S., 2015 - 2025
  • Chart 6-12: Third-Party Refurbished Endoscope Market, U.S., 2015 - 2025
  • Chart 6-13: Leading Competitors, Gastrointestinal Endoscope Market, U.S., 2018
  • Chart 6-14: Leading Competitors, Third-Party Endoscope Refurbishment and Repair Market, U.S., 2018
  • Chart 7-1: Capsule Endoscopy Market by Segment, U.S., 2015 - 2025
  • Chart 7-2: Capsule Endoscopy Market Breakdown, U.S., 2018
  • Chart 7-3: Capsule Endoscopy Market Breakdown, U.S., 2025
  • Chart 7-4: Camera Capsule Market, U.S., 2015 - 2025
  • Chart 7-5: Workstation Market, U.S., 2015 - 2025
  • Chart 7-6: Data Recorder Market, U.S., 2015 - 2025
  • Chart 7-7: Leading Competitors, Capsule Endoscopy Market, U.S., 2018
  • Chart 8-1: Virtual Colonoscopy Software Market, U.S., 2015 - 2025
  • Chart 8-2: Leading Competitors, Virtual Colonoscopy Software Market, U.S., 2018
  • Chart 9-1: Stenting and Dilation Device Market by Segment, U.S., 2015 - 2025
  • Chart 9-2: Stenting and Dilation Device Market Breakdown, U.S., 2018
  • Chart 9-3: Stenting and Dilation Device Market Breakdown, U.S., 2025
  • Chart 9-4: Esophageal Stent Market by Segment, U.S., 2015 - 2025
  • Chart 9-5: Total Esophageal Stent Market, U.S., 2015 - 2025
  • Chart 9-6: Esophageal Covered-Metal Stent Market, U.S., 2015 - 2025
  • Chart 9-7: Esophageal Bare-Metal Stent Market, U.S., 2015 - 2025
  • Chart 9-8: Esophageal Plastic Stent Market, U.S., 2015 - 2025
  • Chart 9-9: Duodenal Stent Market, U.S., 2015 - 2025
  • Chart 9-10: Colonic Stent Market, U.S., 2015 - 2025
  • Chart 9-11: Esophageal Dilation Balloon Market by Segment, U.S., 2015 - 2025
  • Chart 9-12: Total Esophageal Dilation Balloon Market, U.S., 2015 - 2025
  • Chart 9-13: Multi-Stage Esophageal Dilation Balloon Market, U.S., 2015 - 2025
  • Chart 9-14: Single-Stage Esophageal Dilation Balloon Market, U.S., 2015 - 2025
  • Chart 9-15: Duodenal Dilation Balloon Market, U.S., 2015 - 2025
  • Chart 9-16: Colonic Dilation Balloon Market, U.S., 2015 - 2025
  • Chart 9-17: Leading Competitors, Stenting and Dilation Device Market, U.S., 2018
  • Chart 9-18: Leading Competitors, Esophageal Stent Market, U.S., 2018
  • Chart 10-1: ERCP Device Market by Segment, U.S., 2015 - 2025
  • Chart 10-2: ERCP Device Market Breakdown, U.S., 2018
  • Chart 10-3: ERCP Device Market Breakdown, U.S., 2025
  • Chart 10-4: Sphincterotome Market, U.S., 2015 - 2025
  • Chart 10-5: Biliary Stone Removal Balloon Market, U.S., 2015 - 2025
  • Chart 10-6: Biliary Stone Removal Basket Market, U.S., 2015 - 2025
  • Chart 10-7: Biliary Dilation Balloon Market, U.S., 2015 - 2025
  • Chart 10-8: Biliary and Pancreatic Stent Market by Segment, U.S., 2015 - 2025
  • Chart 10-9: Total Biliary and Pancreatic Stent Market, U.S., 2015 - 2025
  • Chart 10-10: Biliary and Pancreatic Covered-Metal Stent Market by Segment, U.S., 2015 - 2025
  • Chart 10-11: Total Biliary and Pancreatic Covered-Metal Stent Market, U.S., 2015 - 2025
  • Chart 10-12: Biliary and Pancreatic Standard Covered-Metal Stent Market, U.S., 2015 - 2025
  • Chart 10-13: Biliary and Pancreatic Lumen-Apposing Covered-Metal Stent Market, U.S., 2015 - 2025
  • Chart 10-14: Biliary and Pancreatic Bare-Metal Stent Market, U.S., 2015 - 2025
  • Chart 10-15: Biliary and Pancreatic Plastic Stent Market, U.S., 2015 - 2025
  • Chart 10-16: Biliary Lithotripter Market, U.S., 2015 - 2025
  • Chart 10-17: ERCP Guidewire Market, U.S., 2015 - 2025
  • Chart 10-18: ERCP Cannula Market, U.S., 2015 - 2025
  • Chart 10-19: Leading Competitors, ERCP Device Market, U.S., 2018
  • Chart 10-20: Leading Competitors, Biliary and Pancreatic Stent Market, U.S., 2018
  • Chart 11-1: Biopsy Forceps, Polypectomy Snare and EUS Needle Market by Segment, U.S., 2015 - 2025
  • Chart 11-2: Biopsy Forceps, Polypectomy Snare and EUS Needle Market Breakdown, U.S., 2018
  • Chart 11-3: Biopsy Forceps, Polypectomy Snare and EUS Needle Market Breakdown, U.S., 2025
  • Chart 11-4: Biopsy Forceps Market by Segment, U.S., 2015 - 2025
  • Chart 11-5: Total Biopsy Forceps Market, U.S., 2015 - 2025
  • Chart 11-6: Cold Disposable Biopsy Forceps Market, U.S., 2015 - 2025
  • Chart 11-7: Hot Disposable Biopsy Forceps Market, U.S., 2015 - 2025
  • Chart 11-8: Cold Reusable Biopsy Forceps Market, U.S., 2015 - 2025
  • Chart 11-9: Hot Reusable Biopsy Forceps Market, U.S., 2015 - 2025
  • Chart 11-10: Polypectomy Snare Market, U.S., 2015 - 2025
  • Chart 11-11: EUS Needle Market by Segment, U.S., 2015 - 2025
  • Chart 11-12: Total EUS Needle Market, U.S., 2015 - 2025
  • Chart 11-13: Fine Needle Aspiration Market, U.S., 2015 - 2025
  • Chart 11-14: Fine Needle Biopsy Market, U.S., 2015 - 2025
  • Chart 11-15: Leading Competitors, Biopsy Forceps, Polypectomy Snare and EUS Needle Market, U.S., 2018
  • Chart 11-16: Leading Competitors, Biopsy Forceps Market, U.S., 2018
  • Chart 11-17: Leading Competitors, EUS Needle Market, U.S., 2018
  • Chart 12-1: Specimen retrieval and foreign-body removal Device Market by Segment, U.S., 2015 - 2025
  • Chart 12-2: Specimen retrieval and foreign-body removal Device Market Breakdown, U.S., 2018
  • Chart 12-3: Specimen retrieval and foreign-body removal Device Market Breakdown, U.S., 2025
  • Chart 12-4: Specimen Retrieval Device Market by Segment, U.S., 2015 - 2025
  • Chart 12-5: Total Specimen Retrieval Device Market, U.S., 2015 - 2025
  • Chart 12-6: Polyp Retrieval Trap Market, U.S., 2015 - 2025
  • Chart 12-7: Specimen Retrieval Net Market, U.S., 2015 - 2025
  • Chart 12-8: Foreign-Body Removal Device Market by Segment, U.S., 2015 - 2025
  • Chart 12-9: Total Foreign-Body Removal Device Market, U.S., 2015 - 2025
  • Chart 12-10: Foreign-Body Removal Net Market, U.S., 2015 - 2025
  • Chart 12-11: Foreign-Body Removal Grasper Market, U.S., 2015 - 2025
  • Chart 12-12: Foreign-Body Removal Snare Market, U.S., 2015 - 2025
  • Chart 12-13: Leading Competitors, Specimen Retrieval and Foreign-Body Removal Device Market, U.S., 2018
  • Chart 12-14: Leading Competitors, Specimen Retrieval Device Market, U.S., 2018
  • Chart 12-15: Leading Competitors, Foreign-Body Removal Device Market, U.S., 2018
  • Chart 13-1: Hemostasis Device Market by Segment, U.S., 2015 - 2025
  • Chart 13-2: Hemostasis Device Market Breakdown, U.S., 2018
  • Chart 13-3: Hemostasis Device Market Breakdown, U.S., 2025
  • Chart 13-4: Electrosurgical Generator Market by Segment, U.S., 2015 - 2025
  • Chart 13-5: Total Electrosurgical Generator Market, U.S., 2015 - 2025
  • Chart 13-6: Electrosurgical Unit Market, U.S., 2015 - 2025
  • Chart 13-7: Argon Module Market, U.S., 2015 - 2025
  • Chart 13-8: Hemostasis Probe Market by Segment, U.S., 2015 - 2025
  • Chart 13-9: Total Hemostasis Probe Market, U.S., 2015 - 2025
  • Chart 13-10: Electrosurgical Probe Device Market by Segment, U.S., 2015 - 2025
  • Chart 13-11: Total Electrosurgical Probe Market, U.S., 2015 - 2025
  • Chart 13-12: Conventional Electrosurgical Probe Market, U.S., 2015 - 2025
  • Chart 13-13: Injection-Needle Probe Market, U.S., 2015 - 2025
  • Chart 13-14: Heat Probe Market, U.S., 2015 - 2025
  • Chart 13-15: Argon Probe Market, U.S., 2015 - 2025
  • Chart 13-16: Ligation Device Market by Segment, U.S., 2015 - 2025
  • Chart 13-17: Total Ligation Device Market, U.S., 2015 - 2025
  • Chart 13-18: Ligation Band Market, U.S., 2015 - 2025
  • Chart 13-19: Ligation Clip Market, U.S., 2015 - 2025
  • Chart 13-20: Sclerotherapy Needle Market, U.S., 2015 - 2025
  • Chart 13-21: Leading Competitors, Hemostasis Device Market, U.S., 2018
  • Chart 13-22: Leading Competitors, Electrosurgical Generator Market, U.S., 2018
  • Chart 13-23: Leading Competitors, Hemostasis Probe Market, U.S., 2018
  • Chart 13-24: Leading Competitors, Electrosurgical Probe Market, U.S., 2018
  • Chart 13-25: Leading Competitors, Ligation Device Market, U.S., 2018
  • Chart 14-1: Enteral Feeding Device Market by Segment, U.S., 2015 - 2025
  • Chart 14-2: Enteral Feeding Device Market Breakdown, U.S., 2018
  • Chart 14-3: Enteral Feeding Device Market Breakdown, U.S., 2025
  • Chart 14-4: Enteral Feeding Pump Market, U.S., 2015 - 2025
  • Chart 14-5: Feeding Tube Market by Segment, U.S., 2015 - 2025
  • Chart 14-6: Total Feeding Tube Market, U.S., 2015 - 2025
  • Chart 14-7: PEG Tube Market by Segment, U.S., 2015 - 2025
  • Chart 14-8: Total PEG Tube Market, U.S., 2015 - 2025
  • Chart 14-9: Initial Placement PEG Tube Market, U.S., 2015 - 2025
  • Chart 14-10: Replacement PEG Tube Market by Segment, U.S., 2015 - 2025
  • Chart 14-11: Total Replacement PEG Tube Market, U.S., 2015 - 2025
  • Chart 14-12: Replacement Traditional Tube Market, U.S., 2015 - 2025
  • Chart 14-13: Replacement Low-Profile Balloon Tube Market, U.S., 2015 - 2025
  • Chart 14-14: Replacement Low-Profile Non-Balloon Tube Market, U.S., 2015 - 2025
  • Chart 14-15: DPEJ Tube Market, U.S., 2015 - 2025
  • Chart 14-16: PEG-J Tube Market, U.S., 2015 - 2025
  • Chart 14-17: NG/NJ Tube Market, U.S., 2015 - 2025
  • Chart 14-18: Feeding Set Market, U.S., 2015 - 2025
  • Chart 14-19: Leading Competitors, Enteral Feeding Device Market, U.S., 2018
  • Chart 14-20: Leading Competitors, Feeding Tube Market, U.S., 2018
  • Chart 14-21: Leading Competitors, PEG Tube Market, U.S., 2018
  • Chart 15-1: Anti-Reflux Device Market, U.S., 2015 - 2025
  • Chart 15-2: Leading Competitors, Anti-Reflux Device Market, U.S., 2018
  • Chart 16-1: Barrett's Esophagus Ablation Device Market by Segment, U.S., 2015 - 2025
  • Chart 16-2: Barrett's Esophagus Ablation Device Market Breakdown, U.S., 2018
  • Chart 16-3: Barrett's Esophagus Ablation Device Market Breakdown, U.S., 2025
  • Chart 16-4: Ablation Device Market, U.S., 2015 - 2025
  • Chart 16-5: Ablation Catheter Market, U.S., 2015 - 2025
  • Chart 16-6: Leading Competitors, Barrett's Esophagus Ablation Device Market, U.S., 2018

LIST OF FIGURES

  • Figure 16-1: Endoscopic Gastrointestinal Device Market Share Ranking by Segment, U.S., 2018 (1 of 3)
  • Figure 16-2: Endoscopic Gastrointestinal Device Market Share Ranking by Segment, U.S., 2018 (2 of 3)
  • Figure 16-3: Endoscopic Gastrointestinal Device Market Share Ranking by Segment, U.S., 2018 (3 of 3)
  • Figure 16-4: Companies Researched in this Report
  • Figure 16-5: Factors Impacting the Endoscopic Gastrointestinal Device Market by Segment, U.S. (1 of 2)
  • Figure 16-6: Factors Impacting the Endoscopic Gastrointestinal Device Market by Segment, U.S. (2 of 2)
  • Figure 16-7: Recent Events in the Endoscopic Gastrointestinal Device Market, U.S., 2016 - 2018
  • Figure 16-8: Endoscopic Gastrointestinal Device Procedures Covered
  • Figure 16-9: Procedure Codes Investigated
  • Figure 16-10: Endoscopic Gastrointestinal Device Markets Covered (1 of 3)
  • Figure 16-11: Endoscopic Gastrointestinal Device Markets Covered (2 of 3)
  • Figure 16-12: Endoscopic Gastrointestinal Device Markets Covered (3 of 3)
  • Figure 16-13: Key Report Updates
  • Figure 16-14: Version History
  • Figure 2-1: General Statistic of Digestive Diseases: All Digestive Diseases, U.S., 2004 - 2010
  • Figure 3-1: Gastrointestinal Endoscopy by Company (1 of 3)
  • Figure 3-2: Gastrointestinal Endoscopy by Company (2 of 3)
  • Figure 3-3: Gastrointestinal Endoscopy by Company (3 of 3)
  • Figure 3-4: Capsule Endoscopy by Company
  • Figure 3-5: Virtual Colonoscopy by Company
  • Figure 3-6: Stenting and Dilation Devices by Company
  • Figure 3-7: ERCP Devices by Company (1 of 3)
  • Figure 3-8: ERCP Devices by Company (2 of 3)
  • Figure 3-9: ERCP Devices by Company (3 of 3)
  • Figure 3-10: Biopsy Forceps, Polypectomy Snares, Fine Aspiration Needles by Company
  • Figure 3-11: Foreign Body Retrieval and Specimen Removal Devices by Company
  • Figure 3-12: Hemostasis Devices by Company
  • Figure 3-13: Enteral Feeding Devices by Company (1 of 3)
  • Figure 3-14: Enteral Feeding Devices by Company (2 of 3)
  • Figure 3-15: Enteral Feeding Devices by Company (3 of 3)
  • Figure 3-16: Anti-Reflux Devices by Company
  • Figure 3-17: Barrett's Esophagus Ablation Devices by Company
  • Figure 3-18: Class 2 Device Recall Spyscope DS Access and Delivery Catheter
  • Figure 3-19:Class 2 Device Recall Extractor Pro RX
  • Figure 3-20: Class 2 Device Recall Expel Drainage Catheter with TwistLoc Hub Biliary Drainage Catheter and BiliaryDrainage Catheter Kit
  • Figure 3-21: Class 2 Device Recall Boston Scientific Extractor Pro XL Retrieval Balloon Catheter
  • Figure 3-22: Class 2 Device Recall Advance 35LP LowProfile PTA Balloon Dilatation Catheter
  • Figure 3-23: Class 2 Device Recall CheckFlo Introducer
  • Figure 3-24: Class 2 Device Recall Flexor CheckFlo Introducer
  • Figure 3-25: Class 2 Device Recall Ring Transjugular Intrahepatic Access Set & Flexor RTPS Guiding Sheath
  • Figure 3-26: Class 2 Device Recall Transluminal Biliary Biopsy Forceps Set
  • Figure 3-27: Class 2 Device Recall CheckFlo Hemostasis Assembly
  • Figure 3-28: Class 2 Device Recall FUJINON ED530XT
  • Figure 3-29: Class 2 Device Recall Fujifilm
  • Figure 3-30: Class 2 Device Recall Fujifilm
  • Figure 3-31: Class 2 Device Recall Fujifilm Endoscope
  • Figure 3-32: Class 2 Device Recall Dudenoscope
  • Figure 3-33: Class 2 Device Recall Fujifilm
  • Figure 3-34: Class 2 Device Recall Fujifilm
  • Figure 3-35: Class 2 Device Recall CORTRAK 2 Nasogastric/Nasointestinal (NG/NI) Feeding Tubes w/ ANTIIV Connector
  • Figure 3-36: Class 2 Device Recall OERPro Endoscope Reprocessor
  • Figure 3-37: Class 2 Device Recall EVIS EXERA Duodenovideoscope OLYMPUS TJF 160F/VF
  • Figure 3-38: Class 2 Device Recall Evis Exera II Duodenovideoscope Olympus TJFQ180V
  • Figure 3-39: Class 2 Device Recall MAJ1606 Instrument Channel Adaptor
  • Figure 3-40: Class 2 Device Recall EVIS EXERA II Gastrovideoscope OLYMPUS GF type UCT180
  • Figure 3-41: Class 2 Device Recall EVIS EXERA II Duodenovideoscope OLYMPUS TJF TypeQ180V
  • Figure 3-42: Class 2 Device Recall Pentax Video Duodenoscope
  • Figure 3-43: Class 2 Device Recall Ultrasound Video Gastroscope
  • Figure 3-44: Class 2 Device Recall
  • Figure 3-45: Class 2 Device Recall Pentax Video Duodenoscope
  • Figure 3-46: Class 2 Device Recall Pentax
  • Figure 3-47: Class 2 Device Recall Pentax Video Gastroscope
  • Figure 3-48: Class 2 Device Recall Pentax
  • Figure 3-49: Class 2 Device Recall Pentax
  • Figure 3-50: Class 2 Device Recall Pentax Medical
  • Figure 3-51: Class 2 Device Recall Pentax Medical Inc.
  • Figure 3-52: Class 2 Device Recall Pentax Medical Inc.
  • Figure 3-53: Class 3 Device Recall Roth Net Polyp Retrieval
  • Figure 3-54: Class 2 Device Recall Talon Grasping Device
  • Figure 3-55: Comparison of FCSEMS and Plastic Stents (WON-MVP)
  • Figure 3-56: AXIOS Lumen Apposing Metal Stent for Walled Off Necrosis Drainage IDE Study
  • Figure 3-57: WallFlex Esophageal Fully Covered (FC) Benign Anastomotic Stricture
  • Figure 3-58: TECR & ECM Placement for Esophageal High Grade Dysplasia
  • Figure 3-59: A Trial of Esophageal and Gastric Stenting for Leak or Perforation (ESO-stent)
  • Figure 3-60: Colonic Stenting With Elective Surgery Versus Emergency Surgery in the Management of Acute Malignant Colonic Obstruction
  • Figure 3-61: Esophageal Fully Covered Metal Stents in Caustic Strictures Study
  • Figure 3-62: Fully Covered or Partially Covered Stents in Malignant Esophageal Strictures (COPAC)
  • Figure 3-63: Treatment of Malignant Strictures in Esophagus and Gastroesophageal Junction With Covered or Partially Covered Stent. (StentMig)
  • Figure 3-64: Cholangioscopic Classification of Bile Duct Lesions
  • Figure 3-65: Single-operator Digital Cholangioscopy for the Diagnosis of Malignant and Benign Biliary Strictures
  • Figure 3-66: SpyGlass AMEA Registry
  • Figure 3-67: Endoscopic Retrograde Cholangiopancreatography (ERCP) Based Sampling of Indeterminate Bile Duct Strictures
  • Figure 3-68: POCS in Liver Transplantation Patients
  • Figure 3-69: SpyGlass Direct Visualization System Clinical Registry in China (SpyChina)
  • Figure 3-70: Effect of Endoscopic Papillary Large Balloon Dilation on Recurrent Rate of Patients With Recurrentstones in Bile Duct
  • Figure 3-71: Effect of Endoscopic Papillary Balloon Dilation on ERCP Complications
  • Figure 3-72: Self-expandable Metallic Stent Versus Multiple Plastic Stents in Post Orthotopic Liver Transplantation Biliary Stenosis
  • Figure 3-73: Prospective Evaluation of Residual Bile Duct Stone by Peroral Cholangioscopy After Conventional ERCP
  • Figure 3-74: Prospective Evaluation of the Ability of Spyglass Cholangioscopy to Facilitate Radiation Free ERCP
  • Figure 3-75: Endoscopic Biliary RFA of Malignant Bile Duct Obstruction
  • Figure 3-76: Efficacy and Safety of Photodynamic Therapy for Unresectable Cholangiocarcinoma
  • Figure 3-77: Endoscopic Treatment of Difficult Bile Duct Stones: Spyglass + EHL x Balloon Dilation of the Papilla (EHL)
  • Figure 3-78: WallFlex Biliary Fully Covered (FC) Chronic Pancreatitis Study
  • Figure 3-79: Short Term Pancreatic Stenting Registry
  • Figure 3-80: Preoperative Biliary Drainage With Metal Versus Plastic Stents in Periampullary Cancer
  • Figure 3-81: Covered vs Uncovered Metal Stents for Palliative Biliary Decompression in Inoperable Malignant Distal Bile Duct Obstruction
  • Figure 3-82: Digital SpyGlass Confirmed Common Bile Duct Stones Clearance Without Fluoroscopy
  • Figure 3-83: Balloon Catheter vs. Basket Catheter for Endoscopic Bile Duct Stone Extraction
  • Figure 3-84: Non-Complex Biliary Stones DSC vs ERC
  • Figure 3-85: Pancreatic Metal Stents in Chronic Pancreatitis
  • Figure 3-86: WallFlex Pancreatic Metal Stent for Pancreatic Duct Strictures
  • Figure 3-87: WallFlex Biliary Fully Covered (FC) Benign Stricture Study
  • Figure 3-88: Prospective, Multi-Center All-Comer Biliary Canadian WallFlex Registry
  • Figure 3-89: Preoperative Biliary Drainage in Resectable Pancreatic or Periampullary Cancer
  • Figure 3-90: Pancreatic Duct Stenting to Prevent Postoperative Pancreatic Fistula (POPF) After Distal Pancreatectomy
  • Figure 3-91: Pre-operative Biliary SEMS RCT During Neoadjuvant Therapy
  • Figure 3-92: Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma
  • Figure 3-93: Laser Lithotripsy for Difficult Large Bile Duct Stones
  • Figure 3-94: Endodrill vs. Conventional Biopsy. Evaluation of Diagnostic Capacity in Diffuse Gastric Cancer
  • Figure 3-95: EUS GUIDED Transduodenal Biopsy Using the 19G Flex (NIFLEX)
  • Figure 3-96: EUS-CNB Versus EUS-SINK for Diagnosis of Upper Gastrointestinal (UGI) Subepithelial Tumors
  • Figure 3-97: Biopsy Forceps Versus Cold Snare for the Resection of Small Colonic Polyps
  • Figure 3-98: EUS FNB Versus FNA With On-Site Cytopathology in Solid Pancreatic Masses
  • Figure 3-99: Endoscopic Ultrasound (EUS) Guided Fine Needle Aspiration (FNA) EUS-FNA of Solid Pancreatic Mass Lesions Using a Novel Corkscrew Technique: a Pilot Study
  • Figure 3-100: Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial.
  • Figure 3-101: Endoscopic Ultrasonography (EUS) Guided Fine Needle Aspiration Using Free Stylet 22g and 25 g Needles
  • Figure 3-102: Comparison of Two Needle Aspiration Techniques for Endoscopic Ultrasound-guided Fine Needle Aspiration (EUS-FNA) in Solid Pancreatic Lesions
  • Figure 3-103: Evaluation of PCLs Using Three EUS-FNA Needles
  • Figure 3-104: EUS-FNA of Solid Pancreatic Mass: Comparison Between Negative Pressure and Slow-pull Technique (EUS-FNA)
  • Figure 3-105: Vela China Study: in Cutting And Hemostasis For Gastrointestinal Epithelial Neoplasia In Chinese Population
  • Figure 3-106: Removal of the Evolution® Esophageal Stent - Fully Covered (CLARITY)
  • Figure 3-107: SX ELLA Esophageal Degradable BD Stent System (DESTINY)
  • Figure 3-108: Using Covered Stent of Diameter of 7mm in TIPS
  • Figure 3-109: Comparison of Covered and Bare Stent in TIPS
  • Figure 3-110: Evolution® Biliary Stent System Clinical Study
  • Figure 3-111: Pancreatic Stent for Distal Pancreatectomy
  • Figure 3-112: Endoscopic Nasogallbladder Drainage Versus Gallbladder Stenting Before Cholecystecomy
  • Figure 3-113: Prospective Random Comparing Study on EUS-guided Pseudocyst Drainage by Naso-pancreatic Tube and Stents
  • Figure 3-114: Comparison Between Fully Covered Metal Stents and Plastic Stents in Preoperative Biliary Drainage
  • Figure 3-115: Evolution® Biliary Stent System-Fully Covered
  • Figure 3-116: Pancreatic Duct Stent for Acute Necrotizing Pancreatitis
  • Figure 3-117: Endoscopic Biliary Drainage in Malignant High Grade Biliary Stricture
  • Figure 3-118: Comparison of Endoscopic Sphincterotomy Plus Large-balloon Dilatation and Conventional Treatment for Large CBD Stones
  • Figure 3-119: Comparison of Loop-tip Cook Medical® Wire Versus Traditional Endoscopic Technique (loop)
  • Figure 3-120: Comparison Of Loop-Tip Wire Vs Traditional Technique In The Cannulation Of The Common Bile Duct
  • Figure 3-121: Prospective Trial of EUS-FNA Versus EUS-FNB Using a Novel Core Biopsy Needle (MUCIN)
  • Figure 3-122: Yield Rate for Procurement the Histologic Core With Endoscopic Ultrasound-guided Fine Needle Biopsy With 20-gauge Ultrasound Biopsy Needles for Solid Pancreatic Masses: Pilot Study
  • Figure 3-123: Endoscopic Ultrasound-guided Fine Needle Biopsy With 25-gauge Biopsy Needles for Solid Pancreatic Masses
  • Figure 3-124: Head to Head Comparison of Two Needles EUS Guided FNB
  • Figure 3-125: Comparison of Jumbo and Hot Biopsy Forceps
  • Figure 3-126: Diagnostic Yield of 20-gauge Procore Needle for EUS-guided FNA Biopsy in Solid Pancreatic Lesions
  • Figure 3-127: EUS-FNA With 22G Procore Needles vs 22G Conventional Needles
  • Figure 3-128: A Multicenter Trial, Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS ProCore Fine Needle Biopsy (FNB) Device (ASPRO)
  • Figure 3-129: Comparison of EUS-Guided Fine Needle Aspiration Technique
  • Figure 3-130: Comparison of Back-loaded vs Preloaded Fiducial Needles in EUS-guided Fiducial Marker Placement in Pancreatic Cancer.
  • Figure 3-131: Evaluation of Multiple Needle Use in EUS-FNA for Pancreatic Cancer (EMUNE-07)
  • Figure 3-132: EUS-guided Glue Injection for Varices Study
  • Figure 3-133: Study of Hemospray for Lower Gastrointestinal Hemorrhage
  • Figure 3-134: RCT to Determine the Efficacy of Combining Hemospray With Medical Treatment in Acute Variceal Bleeding
  • Figure 3-135: Hemospray Versus the Combined Conventional Technique for Endoscopic Hemostasis of Bleeding Peptic Ulcers : A Pilot Study
  • Figure 3-136: The EndoGastric Solutions TEMPO Trial (TEMPO)
  • Figure 3-137: Retrospective TIF Study for Treatment of Gastroesophageal Reflux Disease (GERD). The RetroTIF Study (RetroTIF)
  • Figure 3-138: Randomized EsophyX Versus Sham / Placebo Controlled TIF Trial: The RESPECT Study (RESPECT)
  • Figure 3-139: Hernia Reduction Prior to Scheduled TIF Completion (HEURISTIC)
  • Figure 3-140: Transoral Incisionless Fundoplication (TIF) Registry Study for Treatment of Gastroesophageal Reflux Disease (GERD)
  • Figure 3-141: Transoral Incisionless Fundoplication (TIF) Versus Sham for Treatment of Gastroesophageal Reflux Disease (GERD)
  • Figure 3-142: Registry to Compare Two Surgical Treatments for GERD (STAR Registry)
  • Figure 3-143: Cryobiopsy or Forceps Biopsy During Semirigid Thoracoscopy: a Comparative Study
  • Figure 3-144: Hybrid APC Assisted EMR for Large Colon Polyps
  • Figure 3-145: PROSpective Assessment of Post EmR Recurrence (PROSPER)
  • Figure 3-146: A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the Pancreas (RADIOCYST01)
  • Figure 3-147: Minimal Risk Registry of Endoscopic Image and Pathology Correlation for Fujiflim
  • Figure 3-148: Resect and Discard Extension to FICE of NIcE Classification (FICE;NICE)
  • Figure 3-149: ColoAssist vs. MEI
  • Figure 3-150: Linked Color Imaging Based CMV Diagnosis for Gastric Mucosal Lesions
  • Figure 3-151: Linked-color Imaging for the Detection of Colorectal Flat Lesions
  • Figure 3-152: Linked Color Imaging/Magnifying Blue Laser Imaging vs. White Light for Adenomas and Serrated Lesions in Proximal Colon
  • Figure 3-153: Blue Laser Imaging and White Light Imaging Colonic Polyps
  • Figure 3-154: Linked Color Imaging Versus High-definition White Light Endoscopy for the Detection of Polyps in Patients With Lynch Syndrome (LCI-LYNCH)
  • Figure 3-155: Double-balloon Colonoscopy to Increase Colonoscopy Completion Rate
  • Figure 3-156: Clinical Study Comparing PillCam® Crohn's Capsule Endoscopy to Ileocolonoscopy (IC) Plus MRE for Detection of Active CD in the Small Bowel and Colon in Subjects With Known CD and Mucosal Disease (BLINK)
  • Figure 3-157: A Treat-to-target Strategy Using Pan-enteric Capsule Endoscopy (PCE) in Paediatric Crohn's Disease (CD). (PCE)
  • Figure 3-158: Monitoring Disease Activity Using Video Capsule Endoscopy (VCE) in Crohn's Disease (CD) Subjects
  • Figure 3-159: Evaluation the Efficacy of Colon Capsule Endoscopy (CCE) Versus Computed Tomographic Colonography (CTC) in the Identification of Colonic Polyps in a Screening Population. (TOPAZ)
  • Figure 3-160: Evaluation of PillCam IBD Capsule Endoscopy System in Visualization of Lesions in the Colon Indicative of Ulcerative Colitis Disease (UC)
  • Figure 3-161: Optimization of the Bowel Preparation Regimen for the PillCam® COLON 2 Capsule Endoscopy Procedure
  • Figure 3-162: Development of Applications of PillCam™ Endoscopy and Patency Systems and Clinical Evaluation of Their Performance in Healthy Volunteers ("HEIGHT" Study)
  • Figure 3-163: Development of Applications of the ® PillCam Endoscopy System and Evaluation of Their Performance (NOISE)
  • Figure 3-164: Evaluation of Performance Characteristics of Capsule Endoscopy With PillCam UGI Capsule Compared to Standard Endoscopy
  • Figure 3-165: Capsule Colonoscopy in Crohn's Disease and Its Correlation With Conventional Colonoscopy and Faecal Calprotectin
  • Figure 3-166: Capsule Endoscopy for Hemorrhage in the Emergency Room (CHEER)
  • Figure 3-167: Capsule Endoscopy for HEmorrhage in the ER (CHEER)
  • Figure 3-168: PillCam SBC System Functionality in Established and Suspected IBD Patients (PIANO)
  • Figure 3-169: Retrospective Collection of PillCam SB Movies (OCEAN)
  • Figure 3-170: Clinical Management With SPM System and Validation of the SPM 5 Hour Cutoff in Patients With Symptoms of Gastroparesis
  • Figure 3-171: Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening (FAMCAP)
  • Figure 3-172: RFA for Flat Type High-grade and Medium-grade Intraepithelial Squamous Neoplasia (REACH)
  • Figure 3-173: A Safety and Tolerability of Circumferential Anal Canal Radiofrequency Ablation For Anal Intraepithelial Neoplasia
  • Figure 3-174: A Trial of Radiofrequency Ablation for Anal Intraepithelial Neoplasia Using the HALO Ablation System (AIN)
  • Figure 3-175: Radiofrequency Ablation for the Treatment of Large Symptomatic Heterotopic Gastric Mucosa (RAGE)
  • Figure 3-176: The EMPrint™ Ablate and RESect Study in Patients With Metastatic Lung Tumors (EMPRESS) (EMPRESS)
  • Figure 3-177: Radiofrequency Ablation in Patients With Barrett's Esophagus (RABE)
  • Figure 3-178: HALO Patient Registry: Ablation of Barrett's Esophagus
  • Figure 3-179: Ablation of Intestinal Metaplasia Containing Dysplasia
  • Figure 3-180: Endoscopic Prevention of Esophageal Cancer at Tenwek Hospital (EXPECT)
  • Figure 3-181: Cytosponge Adequacy Study Evaluation II (CASEII)
  • Figure 3-182: Non-Endoscopic Surveillance for Barrett's Esophagus Following Ablative Therapy